New website coming soon
Research & Innovation
in Making Medicines
Rinn Pharma & Biopharma is part of the Research Ireland-funded Rinn Network, a national initiative empowering radical collaboration between academia, industry, government, and society to address major research and innovation challenges.
ABOUT US
Building on the successful foundations of SSPC
Rinn Pharma & Biopharma is advancing research in patient-centred medicines and sustainable pharmaceutical manufacturing.
Enabling radical collaboration with 74 leading researchers across 12 Irish research institutions, the centre is creating the knowledge, talent, and partnerships needed to shape the future of pharmaceutical and biopharmaceutical innovation.
Leading researchers
Irish research institutions
NEWS
Latest from Rinn Pharma & Biopharma
Insights into Flow and Continuous Systems in Pharmaceutical Manufacturing: Challenges and Opportunities
Ireland’s pharmaceutical sector has transformed over the past 50 years, from an API manufacturing base to a global hub for high value activities including process R&D, formulation, bioprocessing, and biotechnology. A major recent shift has been the adoption of continuous flow technology, offering improvements in safety, efficiency, and flexibility. While integrating flow into a highly regulated environment is complex, Ireland’s ecosystem, multinational API sites, CDMOs, and innovative indigenous companies, has successfully advanced large scale API and RSM manufacture through strong collaboration with regulatory agencies. This commentary highlights key factors enabling this transition and the current state of continuous flow in API/RSM production.
https://doi.org/10.1021/acs.oprd.5c00309
• Adrian M. Daly
• Seán Hardiman
• David Hogan
• Gary Morris
• Robert Moylan
• Barry O’Donovan
• Eoin Power
• Paul Phillips
• Shane Robinson
• Philippe M.C. Roth
• Megan Smyth
• Edmond Magner
• Aisling Arthur
• Gerard P. McGlacken
• Marcus Baumann
• Anita R. Maguire*
Partners: Eli Lilly, MSD, Pfizer, JnJ, sk biotek, apc, almac, WAB, arran chemical, UCC, UCD, UL.
Rinn Pharma & Biopharma PhD opportunities – Positions available 07.10.2026
Rinn Pharma & Biopharma, in partnership with leading research institutions across Ireland, is seeking motivated and talented PhD researchers to join a range of exciting research programmes. Research Themes Include: Cell-Expressed & RNA Therapeutics Advanced...
Sarah Hayes Named Biopharma & Lifesciences Connected Person of the Month for June 2026
Dr Sarah Hayes, Chief Operations Officer at Rinn Pharma & Biopharma, has been named Biopharma & Lifesciences Connected Person of the Month for June 2026. Sarah has been selected in recognition of her outstanding leadership and contribution to Ireland’s...
Limerick Festival of Science events schedule
The Limerick Science Festival returns this November as part of Science Week 2025, running from November 9-16, proudly supported by Research Ireland. This year marks a major milestone, 30 years of Science Week, with the theme “Then. Today. Tomorrow.” inviting us all to...
SSPC Builds Foundation for Ireland’s (Bio)pharmaceutical Future, delivering €1.3 Billion Economic Impact
SSPC, Research Ireland Centre for Pharmaceuticals hosted at University of Limerick, has revealed extraordinary national contributions in its latest impact report. The study highlights over €1.3 billion in economic impact since 2008 and a 26-fold return on core...
SSPC 2024 Research Outputs
SSPC’s 2024 report distills a year of impactful research, industry collaboration, and talent development into a focused snapshot of achievements. From industrial investment to global engagement and sustainable innovation, the report showcases SSPC’s continued...
NEWS
Latest from Rinn Pharma & Biopharma
Insights into Flow and Continuous Systems in Pharmaceutical Manufacturing: Challenges and Opportunities
Ireland’s pharmaceutical sector has transformed over the past 50 years, from an API manufacturing base to a global hub for high value activities including process R&D, formulation, bioprocessing, and biotechnology. A major recent shift has been the adoption of continuous flow technology, offering improvements in safety, efficiency, and flexibility. While integrating flow into a highly regulated environment is complex, Ireland’s ecosystem, multinational API sites, CDMOs, and innovative indigenous companies, has successfully advanced large scale API and RSM manufacture through strong collaboration with regulatory agencies. This commentary highlights key factors enabling this transition and the current state of continuous flow in API/RSM production.
https://doi.org/10.1021/acs.oprd.5c00309
• Adrian M. Daly
• Seán Hardiman
• David Hogan
• Gary Morris
• Robert Moylan
• Barry O’Donovan
• Eoin Power
• Paul Phillips
• Shane Robinson
• Philippe M.C. Roth
• Megan Smyth
• Edmond Magner
• Aisling Arthur
• Gerard P. McGlacken
• Marcus Baumann
• Anita R. Maguire*
Partners: Eli Lilly, MSD, Pfizer, JnJ, sk biotek, apc, almac, WAB, arran chemical, UCC, UCD, UL.

Rinn Pharma & Biopharma PhD opportunities – Positions available 07.10.2026
Rinn Pharma & Biopharma, in partnership with leading research institutions across Ireland, is seeking motivated and talented PhD researchers to join a range of exciting research programmes. Research Themes Include: Cell-Expressed & RNA Therapeutics Advanced...

Sarah Hayes Named Biopharma & Lifesciences Connected Person of the Month for June 2026
Dr Sarah Hayes, Chief Operations Officer at Rinn Pharma & Biopharma, has been named Biopharma & Lifesciences Connected Person of the Month for June 2026. Sarah has been selected in recognition of her outstanding leadership and contribution to Ireland’s...

Rinn Pharma & Biopharma Expands European Research Collaboration Through NordicPharmaTrain Partnership
[Ireland, August 7, 2026] - Rinn Pharma & Biopharma, Ireland’s national centre for Research & Innovation in Making Medicines, is pleased to announce its inclusion in the NordicPharmaTrain (NPT) network, marking a significant step forward in expanding...

















